This new ability to compel activity opens up vast new powers.
More recently, genetic approaches have been used to monitor and manipulate neural activity, opening up new experimental opportunities and challenges.
The recent description and pharmacological validation of reporter mice for in vivo analysis of hormone receptor activity opens new horizons for drug discovery.
The ability of the nanotechnology to enhance catalytic activity opens the potential to replace expensive catalysts with lower amounts of inexpensive nanocatalysts [2].
These peptides were engineered successfully to abolish their agonist functions while retaining parasiticidal activity, opening new research possibilities.
The LIF2 structure strongly suggested an RNA-binding activity, opening interesting and unexplored links between RNA metabolism and LHP1-mediated regulation we wished to further investigate.
The recent discovery that the spliceosome is a target for novel compounds with anticancer activity opens up new therapeutic avenues.
We suggest that releasing activity opens the Smc3/α-kleisin interface, creating a DNA exit gate distinct from its proposed entry gate at the Smc1/3 interface.
This article therefore concludes that the GEAA's activities opened the collaborative window and substantially contributed towards the implementation of the FIT.
